| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |